

HY-16764 · 5 mg
MedChemExpress · Cat: HY-16764
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/avarofloxacin.html
Description
Avarofloxacin JNJ-Q2 is a broad-spectrum fluoroquinolone antibacterial agent being developed for the treatment of acute bacterial skin and skin-structure infections and community-acquired pneumonia with oral activity. Avarofloxacin JNJ-Q2 is an aminoethylidenylpiperidine fluoroquinolone that demonstrates antibacterial effect against numerous Gram-positive bacteria with a mean 0.12 mg/L MIC90 value. Avarofloxacin JNJ-Q2 has potential for treatment of methicillin-resistant Staphylococcus aureus MRSA infections.







